Your Location:
Home >
Browse articles >
TAB1——Potential Biomarker of Paclitaxel Resistance in Ovarian Cancer Based on Label-Free Quantitative Proteomics
TAB1——Potential Biomarker of Paclitaxel Resistance in Ovarian Cancer Based on Label-Free Quantitative Proteomics
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 8, Pages: 168-178(2021)
DOI: 10.13422/j.cnki.syfjx.20210404
Scan QR Code
Full Text(HTML)
Figs( 6 ) Tabs( 8 )
References
Publication Info
Metrics
229
Views
152
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Action Mechanism of Betulinic Acid in Inhibiting Ferroptosis and Improving Non-alcoholic Fatty Liver Disease Based on Bioinformatics and Experimental Validation
Molecular Mechanism of Gypenoside L Inducing Ovarian Cancer Cell Apoptosis by Regulating NUF2 and Influencing Magnesium Homeostasis
Arginine Metabolic Disorder in Heart Failure Rats: Analysis Based on Targeted Metabolomics and Bioinformatics
Shenqi Yiliu Prescription Reverses Cisplatin Resistance in Ovarian Cancer Cells by Regulating PI3K/Akt/mTOR Signaling Pathway-mediated Glycolysis
Exploration in Mechanism of Sini San for Inhibiting Ferroptosis and Ameliorating Isoprenaline-induced Myocardial Infarction in Mice Based on Bioinformatics and Experimental Validation
Related Author
TANG Gaojun
HU Jie
LUO Li
WU Huan
ZHANG Quan
ZHANG Baofang
HONG Yang
ZHANG Di
Related Institution
Clinical Medical College, Guizhou Medical University
Affiliated Hospital of Guizhou Medical University
Liaoning University of Traditional Chinese Medicine(TCM)
Affiliated Hospital of Liaoning University of TCM
Experimental Research Center, China Academy of Chinese Medical Sciences


